Furthermore, Sharma Muhammad et al. (2023) highlighted the value of combining HE4, CA125, and IL-6 for predicting tumor resectability in advanced epithelial ovarian cancer, with HE4 serving as a robust marker for tumor burden and aggressiveness [59]. This evidence concerns the gene WFDC2 and ovarian carcinoma.